Skip to main content
Top

Drugs & Aging

Issue 10/2014

Content (7 Articles)

Therapy in Practice

Management of Fibromyalgia in Older Adults

Mary-Ann Fitzcharles, Peter A. Ste-Marie, Yoram Shir, David Lussier

Review Article

Secondary Prevention of Stroke in the Elderly: Focus on Drug Therapy

Martinson K. Arnan, Gregory L. Burke, Cheryl Bushnell

Short Communication

Pharmacokinetics of Zolpidem from Sublingual Zolpidem Tartrate Tablets In Healthy Elderly Versus Non-Elderly Subjects

David J. Greenblatt, Jerold S. Harmatz, Nikhilesh N. Singh, Frank Steinberg, Thomas Roth, Stephen C. Harris, Ram P. Kapil

Original Research Article

Incidence of Hematologic Toxicity in Older Adults Treated with Gemcitabine or a Gemcitabine-Containing Regimen in Routine Clinical Practice: A Multicenter Retrospective Cohort Study

Marie-Rose B. S. Crombag, Aurelia H. M. de Vries Schultink, Jan H. M. Schellens, Jos H. Beijnen, Alwin D. R. Huitema

Original Research Article

Anticholinergic Medications: An Additional Contributor to Cognitive Impairment in the Heart Failure Population?

Arslan Shaukat, Amir Habib, Kathleen A. Lane, Changyu Shen, Saba Khan, Yaron M. Hellman, Malaz Boustani, Adnan S. Malik

Original Research Article

Psychotropic Medicine Utilization in Older People in New Zealand from 2005 to 2013

Henry C. Ndukwe, June M. Tordoff, Ting Wang, Prasad S. Nishtala

Original Research Article

Adverse Drug Reactions in Elderly Subjects Hospitalized in a Specialized Dementia Management Unit

Lukshe Kanagaratnam, Rachid Mahmoudi, Jean-Luc Novella, Damien Jolly, Moustapha Dramé, Thierry Trenque

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine